News Ford and South Korean partners build $1.2B battery materials plant in Quebec The project is expected to create 345 jobs and produce 45,000 tonnes of cathode active materials per annum Rowan DunneAugust 17, 2023
Silver First Majestic Silver sells Mexico mine to Golden Tag Resources for $27M The past-producing La Parrilla silver mine is situated in the state of Durango Rowan DunneAugust 16, 2023
Mining Summa Silver reports ‘outstanding’ gold and silver recoveries from Nevada project Vein samples at the Hughes project near Tonopah returned recoveries of up to 97.1 per cent gold and 96.7 silver Rowan DunneAugust 16, 2023
Cannabis Organigram secures first cannabis supply agreement in United Kingdom The company will be supplying 4C Labs with 600 kg of medical cannabis flower over the next year Rowan DunneAugust 15, 2023
News Peru Amazon tribe claims to be attacked by 7-ft aliens, authorities say illegal gold miners responsible The tall beings described by one villager as similar to the Green Goblin had metallic suits with jet packs and were unphased by bullets Rowan DunneAugust 15, 2023
AI and Autonomy SK Telecom invests US$100M in AI startup Anthropic for multilingual LLM development The companies have signed a partnership agreement to develop the AI technology for telecommunications providers Rowan DunneAugust 14, 2023
Mining TomaGold inks agreement to acquire 20 Quebec mining properties The company's CEO says it will be a game-changer strategy Rowan DunneAugust 14, 2023
Cannabis Israel to loosen restrictions on medical cannabis, revoke license requirements for patients Pending approval from the country's Ministry of Health, exporting Israeli cannabis to Europe will become a less difficult process too Rowan DunneAugust 11, 2023
Mining Rio Tinto to build major solar power plant for diamond mine in NWT The Anglo-Australian mining giant's plant will have 6,600 solar panels and generate 4,200 megawatts annually Rowan DunneAugust 11, 2023
Psychedelics Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010 Rowan DunneAugust 10, 2023